載入...
COVID‐19 and immunosuppressive therapy in dermatology
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become a...
Na minha lista:
| 發表在: | Dermatol Ther |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435553/ https://ncbi.nlm.nih.gov/pubmed/32770592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.14140 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|